Navigation Links
Sangamo BioSciences Announces Presentation at the UBS Global Life Sciences Conference
Date:9/16/2009

RICHMOND, Calif., Sept. 16 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic(TM) development programs and an overview of the company's business strategy at 1:30 pm ET on Wednesday, September 23, 2009 at the UBS Global Life Sciences Conference which will be held in New York City.

The presentation will be webcast live and may be accessed via a link on the Sangamo BioSciences website in the Investor Relations section http://investor.sangamo.com/index.cfm under Events and Presentations. The presentation will be archived on the Sangamo website for two weeks after the event.

About Sangamo

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development program is currently in Phase 2 clinical trials for evaluation of safety and clinical effect in patients with diabetic neuropathy and ALS. Sangamo also has a Phase 1 clinical trial to evaluate safety and clinical effect of a ZFP Therapeutic for the treatment of HIV/AIDS. Other therapeutic development programs are focused on cancer, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TF) that can control gene expression and, consequently, cell function. Sangamo is also
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sangamos Zinc Finger Nuclease Technology Used to Efficiently Modify Human Stem Cells
2. Sangamo BioSciences Reports Second Quarter 2009 Financial Results
3. Sangamo BioSciences Announces Second Quarter 2009 Conference Call and Webcast
4. Sangamo BioSciences Announces Presentation at the Needham Life Sciences Conference
5. Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research
6. Sangamo BioSciences Announces Publication in Nature of the Use of Zinc Finger Nucleases to Accelerate Precision Trait Stacking in Commercial Crop Species
7. Sangamo BioSciences Announces First Quarter 2009 Conference Call and Webcast
8. Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results
9. Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
10. Sangamo BioSciences Announces Fourth Quarter and Year-End 2008 Conference Call and Webcast
11. Sigma-Aldrich and Sangamo BioSciences Announce the Achievement of Key Throughput Milestone in Research Reagents Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or "the ... results for the six months ended June 30, ... Canadian dollars and presented under International Financial Reporting ... , Announced top-line results related to ... for subjects enrolled in the Phase 2 iDEAL ...
(Date:8/29/2014)... MA, San Antonio, TX (PRWEB) August 29, 2014 ... ISO 9001:2008 and ISO 13485:2003 certified, GAMP® 5 ... has been awarded an international Phase II clinical ... with non-Hodgkin’s lymphoma. , Throughout this trial, Intrinsic ... including, but not limited to, protocol and charter ...
(Date:8/28/2014)... Ind. A new research platform uses ... of tiny structures undergoing stress and heating, ... improve designs for microelectronics and batteries., This ... information about how heating and the surface ... properties. Researchers have discussed the merits of ...
(Date:8/28/2014)... , Aug. 28, 2014   SunTrust Robinson ... three industry veterans to its equity research team ... "Our ongoing expansion in equity research demonstrates our ... unique insights to enhance their investment decision making," ... at STRH.  "We continue to make significant investments ...
Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2New analytical technology reveals 'nanomechanical' surface traits 2New analytical technology reveals 'nanomechanical' surface traits 3SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 2SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 3
... Oct. 4 Auxogyn, Inc., a privately held medical ... that it acquired an exclusive license from Stanford University ... medical practitioners in the field of assisted reproduction to ... fertilization (IVF) procedures. The technology licensed from ...
... CryoLife, Inc. (NYSE: CRY ), an implantable ... today that it has appointed David P. Lang as ...  In this newly created position, Mr. Lang will have ... distribution strategies for PerClot, a novel hemostatic agent that ...
... (SIX: RO, ROG; OTCQX: RHHBY) announced today that the cobas ... 201 system is now available with the CE Mark. It ... human genotypes of parvovirus B19 (B19V) and hepatitis A virus (HAV) ... amplification technology (NAT) test which simultaneously quantifies B19V genotypes 1, 2 ...
Cached Biology Technology:Auxogyn Licenses Non-invasive Embryo Assessment Technology From Stanford University 2David P. Lang Appointed Vice President of CryoLife International, Inc. 2David P. Lang Appointed Vice President of CryoLife International, Inc. 3David P. Lang Appointed Vice President of CryoLife International, Inc. 4First Duplex Test for Parvovirus B19 and Hepatitis A Virus Increases Safety of Human Plasma and Plasma Products 2First Duplex Test for Parvovirus B19 and Hepatitis A Virus Increases Safety of Human Plasma and Plasma Products 3
(Date:8/28/2014)... Yale University researchers have identified a handful of bacterial ... as Crohn,s disease and ulcerative colitis, using patients, own ... are published Aug. 28 in the journal Cell ... intestinal microbiota, which plays a critical role in the ... only a small number of bacterial species affect a ...
(Date:8/28/2014)... researcher and his collaborators have developed an online analytic ... of re-engineering cells for biomedical investigation. CellNet is a ... aid stem cell engineering. Details of CellNet and its ... back-to-back papers in the journal Cell . , ... for all types of cell-based investigations and can potentially ...
(Date:8/28/2014)...  Privacy Advocate and Senior Staff Attorney at the ... the lineup of biometric and mobile commerce experts set ... Summit in Tampa, Florida on ... include Steven Rahman, Director, Technology and Strategy at Samsung, and ... theme of this year,s event is Mobility at the ...
Breaking Biology News(10 mins):Yale study identifies possible bacterial drivers of IBD 2New tool aids stem cell engineering for medical research 2Biometrics UnPlugged Welcomes the Electronic Frontier Foundation's Jennifer Lynch to the Mobility at the Crossroads of Commerce and Privacy Summit 2
... in the form of reduced snowfall in mountains is ... communities through the increased ability of elk to stay at ... groundbreaking study in Nature Climate Change . , ... only showed that the abundance of deciduous trees and their ...
... children delivered by cesarean section have an increased risk of ... Cohort Study (MoBa) suggests that children delivered by cesarean section ... three. This was particularly seen among children without a hereditary ... than 37 000 participants in the MoBa study were used ...
... frequently caused by smoking and exposure to carcinogens in the ... of cancer in men,and women in the U.S. More than ... or less and have not invaded the muscle layer. At ... the burning away of tumors with high energy electricity (fulguration). ...
Cached Biology News:Dramatic links found between climate change, elk, plants, and birds 2Tapping the body's own defenses, researchers look to cutting-edge gene therapy for bladder cancer 2
...
... requiring mass detection but not structural ... Mass spectrometer is ideally suited for ... high performance mass analysis. Typical ... protein detection, micro-satellite DNA characterization and ...
Rat Aortic Smooth Muscle Cells (RAOSMC) (>500,000 cells)...
Rat Dermal Fibroblasts (RDF) (>500,000 cells)...
Biology Products: